Enhanced Tumor Killing by Apo2L/Trail and CPT-11 Co-Treatment Is Associated With P21 Cleavage and Differential Regulation of Apo2L/Trail Ligand and Its Receptors

Oncogene - United Kingdom
doi 10.1038/sj.onc.1205449
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search